Medline ® Abstract for Reference 63
of 'Neuroleptic malignant syndrome'
63
TI
Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy.
AU
Wang HC, Hsieh Y
SO
Mov Disord. 2001;16(4):765.
A 20-year-old psychiatric patient receiving haloperidol treatment developed acute-onset fever, rigidity, and mental changes. Subcutaneous apomorphine was given alone for treatment. The patient had rapid clinical improvement after the treatment. Serial blood examinations showed decline and subsequent normalization of the creatine phosphokinase levels.
AD
Department of Neurology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. drhan@ms1.hinet.net
PMID